期刊文献+

经皮椎体成形术治疗多发性骨髓瘤椎体病变

原文传递
导出
摘要 多发性骨髓瘤是血液系统最常见的恶性肿瘤之,而多发性骨髓瘤骨病会引起溶骨性病变及广泛的骨质疏松,其中椎体骨折是较严重的甚至危及生命的损害之一。超过半数的患者是因为出现了骨折、骨痛等症状来医院就诊,初诊时即已存在骨质破坏。化疗能有效抑制单克隆免疫球蛋白的恶性增生,但对于已经发生不可逆的骨质破坏却无能为力。对于那些存在椎体骨折,尤其是椎体压缩性骨折的患者,除去原发病,脊髓失去保护也时刻威胁着他们的生命状态。
出处 《江苏医药》 CAS 北大核心 2013年第23期2920-2921,共2页 Jiangsu Medical Journal
基金 江苏省医学重点学科(2011-12)
  • 相关文献

参考文献4

  • 1Galibert P, Deramond H, Rosat P, et al. Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty[J]. Neurochirurgie, 1987,33 (2) : 166-168.
  • 2Bosnjakovi P, Risti S, Mrvi M, et al. Management of painful spinal lesions caused by multiple myeloma using pereutaneous acrylic cement inj ection[J]. Acta Chir Iugosl, 2009,56 (4) : 153- 158.
  • 3Yang Z,Tan J,Xu Y,et al. Treatment of MM-associated spinal fracture with percutaneous vertebroplasty(PVP) and chemo- therapy[J]. Eur Spine J, 2012,21 (5) : 912-919.
  • 4谢振卿,李斯丹,徐燕,邱录贵.多发性骨髓瘤骨病的发病机制和靶向治疗研究进展[J].中华血液学杂志,2012,33(3):247-249. 被引量:9

二级参考文献28

  • 1Anderson KC. Oncogenomics to target myeloma in the bone marrow microenvironment. Clin Cancer Res, 2011, 17 : 1225-1233.
  • 2Yaccoby S. Osteoblastogenesis and tumor growth in myeloma. Leuk Lymphoma, 2010, 51 : 213-220.
  • 3Vallet S, Smith MR, Raje N. Novel bone-targeted strategies in on- cology. Clin Cancer Res, 2010, 16: 4084-4093.
  • 4Boyce BF, Xing L. The RANKL/RANK/OPG pathway. Curr Osteoporos Rep, 2007, 5: 98-104.
  • 5Standal T, Seidel C, Hjertner O, et al. Osteoprotegerin is bound, internalized, and degraded by nmhiple myeloma ceils. Blood, 2002, 100: 3002-3007.
  • 6Terpos E, Szydlo R, Apperley JF, et al. Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts snr- viva/in multiple myeloma: proposal for a novel prognostic index. Blood, 2003, 102: 1064-1069.
  • 7Jakob C, Goerke A, Terpos E, et al. Serum levels of total-RANKL in multiple myeloma. Clin Lymphoma Myeloma, 2009, 9: 430- 435.
  • 8Oyajobi BO, Franehin G, Williams PJ, et al. Dual effects of mac- rophage inflammatory protein-l alpha on osteolysis and tumor bur- den in the murine 5TGM1 model of myelmna bone disease. Blood, 2003, 102: 311-319.
  • 9Lentzsch S, Gries M, Janz M, et al. Macrophage inflammatory protein 1-alpha (MIP-I alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) ceils. Blood, 2003, 101 : 3633-2646.
  • 10Zannettino AC, Farrugia AN, Kortesidis A, et al. Elevated serum levels of stromal-derived factor-lalpha are associated with in- creased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer ltes, 2005, 65: 1700-1709.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部